AAPG today
$14.89+$0.01 (+0.07%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourBearish
15 minBearish
5 minConsolidating
Daily trend turns down below $14.46
Key levels
Resistance$16.57
Resistance$15.89
Support$14.47
Support$13.46
Latest news & SEC filings
ProductAscentage Pharma to share study results at 68th ASH Annual Meeting
ProductAscentage Pharma to share four drug candidates' findings at ASH 2026
All AAPG news →About Ascentage Pharma
Ascentage Pharma is a biopharmaceutical company that researches, develops, and sells medicines for cancer and other illnesses. Its approved treatments in China are Olverembatinib and Lisaftoclax, and it also has a pipeline of experimental therapies at various stages of testing. The company carries out operations mainly in China and the United States, and works with partners including Takeda and Innovent on development and commercialization.
Based on the company's 20-F filed Apr 29, 2026.
Nasdaq · Healthcare
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
What Is the Price Target for AAPG?
SEPT Low Target
$33.00
SEPT Mid Target
$45.00
SEPT High Target
$48.00
Analyst Consensus
$45.00
Is AAPG a Buy or Sell Right Now?
Thesis
- •Revenue growing 334.7% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AAPG.
Start Free Trial →Is AAPG Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$45.00
35
Moat Score
NONE
3/9
Piotroski Score
-0.2
Altman Z-Score
What Is Smart Money Doing with AAPG?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Zhai Yifan | officer | Buy | 92,746 | - | May 21, 2026 |
| Zhai Yifan | officer | Buy | 95,575 | - | May 21, 2026 |
| Yang Dajun | director officer | Buy | 95,575 | - | May 21, 2026 |
| Yang Dajun | director officer | Buy | 92,746 | - | May 21, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AAPG Growth Story
Revenue YoY
334.7%
3yr Revenue CAGR
N/A%
EPS Growth YoY
59.8%
FCF Growth YoY
82.7%
Revenue Trend
ACCELERATING
Dark Pool Trades for AAPG
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AAPG, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 09:03:40 | $14.88 | 1,200 | $$18K | SELL |
| 09:02:51 | $14.85 | 2,000 | $$30K | SELL |
| 16:24:02 | $15.05 | 1,338 | $$20K | SELL |
| 20:44:35 | $15.13 | 2,669 | $$40K | BUY |
| 11:31:18 | $15.12 | 2,000 | $$30K | BUY |
5 dark pool trades shown · $$138K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AAPG — frequently asked questions
What is AAPG stock price today?
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) is at $14.89, up 0.07% (+$0.01) at the Nov 13, 2026 close.
Why is AAPG stock moving today?
Latest AAPG news — Nov 4, 2026: Ascentage Pharma to share study results at 68th ASH Annual Meeting · Nov 4, 2026: Ascentage Pharma to share four drug candidates' findings at ASH 2026
What is the AAPG price target?
The average analyst price target for AAPG is $45.00, ranging from $33 to $48, based on 5 analysts. Latest: Citigroup initiates on Oct 14, 2026.
What do analysts rate AAPG?
Analyst ratings for AAPG: 0 Buy, 6 Hold, 0 Sell — consensus Hold.
Did AAPG beat earnings?
AAPG last reported on Aug 19, 2026: EPS -$1.30 vs -$0.22 expected — a miss of 491.0%.
Does AAPG pay a dividend?
AAPG does not currently pay a dividend.
What are AAPG support and resistance levels?
Support: $14.47, $13.46. Resistance: $15.89, $16.57, $17.75.
What are insiders doing with AAPG?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on AAPG?
Nov 4, 2026: Ascentage Pharma to share study results at 68th ASH Annual Meeting · Nov 4, 2026: Ascentage Pharma to share four drug candidates' findings at ASH 2026